Achieve Life Sciences Inc (NASDAQ: ACHV) was given a new $6.00 price target on by analysts at Maxim Group. They now have a "buy" rating on the stock.
Achieve Life Sciences, Inc. - Common Shares (ACHV)
Last achieve life sciences, inc. - common shares earnings: 3/13 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.achievelifesciences.com
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
ACHV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACHV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACHV alerts
High impacting Achieve Life Sciences, Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ACHV
News
- Achieve Life Sciences Appoints Mark Oki as Chief Financial OfficerGlobeNewswire
- Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA [Yahoo! Finance]Yahoo! Finance
- Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDAGlobeNewswire
- Smoking Cessation Pipeline Insight 2024, with Focus on Emerging Drugs Cytisinicline (Achieve Life Sciences), EMB-001(Embera Pharmaceuticals) and SBP-9330 (Camino Pharma) [Yahoo! Finance]Yahoo! Finance
- Achieve Life Sciences, Inc. (NASDAQ: ACHV) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.MarketBeat
ACHV
Earnings
- 11/7/24 - Miss
ACHV
Sec Filings
- 12/9/24 - Form 4
- 12/9/24 - Form 4
- 12/9/24 - Form 3
- ACHV's page on the SEC website